http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2714097-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a111bab2cc6a8b341caba08c0b2f1d76
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01J3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6439
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-0684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-0692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2012-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c41622e4313bdc32040cd1f0a2ff57
publicationDate 2014-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2714097-A1
titleOfInvention Surgical lighting sources for use with fluophore-tagged monoclonal antibodies or fluorophore-tagged tumor avid compounds
abstract The present invention describes -light source devices to provide white and blue (401-510 nm) light for the in vivo identification of diseased tissue using fluorescence based tissue targeting. The light source devices are configured with a variety of LED lights capable of emitting white and blue light with at least one excitation wavelength in the range from about 401 nm to about 500 nm (for example, 470 nm to 495 nm) to irradiate an in vivo body part of a subject containing tumor or diseased tissue. The tumor or diseased tissue has fluorophore-tagged targeting constructs attached. The fluorophores used in the targeting constructs have emission spectra greater than 515 nm. The fluorescence emanating from the fluorescent targeting construct in response to the excitation wavelength is directly viewed with long-pass filtered (515 nm) lenses and is used to determine the location and/or surface area of the diseased tissue in the subject. Fluorescence based surgical identification provides more accurate disease resection.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2838415-A4
priorityDate 2011-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128590515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779

Total number of triples: 26.